Concepedia

Author

Nikolaos Nikolaou

Oxford Centre for Diabetes, Endocrinology and MetabolismORCID

Also Known As

N Nikolaou, N. Nikolaou, N.M. NIKOLAOU, Nikolaos Nikolaou, Nikolaou N, Nikolaou, Nikolaos

71

Publications

970

Citations

13

H-Index

40

Concepts

All Affiliations

Oxford Centre for Diabetes, Endocrinology and MetabolismUniversity of BirminghamUniversity of OxfordChurchill HospitalUniversity Hospitals Birmingham NHS Foundation Trust
NN

About

Nikolaos Nikolaou is an author at Oxford Centre for Diabetes, Endocrinology and Metabolism specializing in medicine, physiology, and metabolism.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

198

2

Endocrinology

3

3

174

3

Health Sciences

2

2

133

4

Cell Biology

2

2

79

5

Biochemistry

1

1

55

Nikolaos Nikolaou

×

15

Publications

934

Citations

13

H-Index

YearCitations

A COMPARISON OF AFFINITY CONSTANTS FOR MUSCARINE‐SENSITIVE ACETYLCHOLINE RECEPTORS IN GUINEA‐PIG ATRIAL PACEMAKER CELLS AT 29°C AND IN ILEUM AT 29°C AND 37°C

R. B. BARLOW, K.J. BERRY, Patricia A. Glenton,

British Journal of Pharmacology

1976

292

Development of Hepatocellular Carcinoma in a Murine Model of Nonalcoholic Steatohepatitis Induced by Use of a High-Fat/Fructose Diet and Sedentary Lifestyle

Joanna Dowman, Laurence Hopkins, Gary Reynolds,

American Journal Of Pathology

2014

112

AKR1D1 is a novel regulator of metabolic phenotype in human hepatocytes and is dysregulated in non-alcoholic fatty liver disease

Nikolaos Nikolaou, Laura Gathercole, Lea Marchand,

Metabolism

2019

80

Loss of 5α-Reductase Type 1 Accelerates the Development of Hepatic Steatosis but Protects Against Hepatocellular Carcinoma in Male Mice

Joanna Dowman, Laurence Hopkins, Gary Reynolds,

Endocrinology

2013

78

Dual-5α-Reductase Inhibition Promotes Hepatic Lipid Accumulation in Man

Jonathan Hazlehurst, Andrei I. Oprescu, Nikolaos Nikolaou,

The Journal of Clinical Endocrinology & Metabolism

2015

67

Modified release and conventional glucocorticoids and diurnal androgen excretion in congenital adrenal hyperplasia

Christopher M. Jones, Ashwini Mallappa, Nicole Reisch,

The Journal of Clinical Endocrinology & Metabolism

2016

56

5α-Reductase Type 2 Regulates Glucocorticoid Action and Metabolic Phenotype in Human Hepatocytes

Maryam Nasiri, Nikolaos Nikolaou, Silvia Parajes,

Endocrinology

2015

55

Modified-Release and Conventional Glucocorticoids and Diurnal Androgen Excretion in Congenital Adrenal Hyperplasia

Jones Cm, Ashwini Mallappa, Nicole Reisch,

Yearbook of pediatric endocrinology

2018

41

11β-HSD1 inhibition in men mitigates prednisolone-induced adverse effects in a proof-of-concept randomised double-blind placebo-controlled trial

Nantia Othonos, Riccardo Pofi, Anastasia Arvaniti,

Nature Communications

2023

35

Optimizing human hepatocyte models for metabolic phenotype and function: effects of treatment with dimethyl sulfoxide (DMSO)

Nikolaos Nikolaou, Charlotte Green, Pippa J. Gunn,

Physiological Reports

2016

30

Page 1